Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Health and Medicine, School of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
PLoS Biol. 2023 May 23;21(5):e3002119. doi: 10.1371/journal.pbio.3002119. eCollection 2023 May.
Phage therapy is a medical form of biological control of bacterial infections, one that uses naturally occurring viruses, called bacteriophages or phages, as antibacterial agents. Pioneered over 100 years ago, phage therapy nonetheless is currently experiencing a resurgence in interest, with growing numbers of clinical case studies being published. This renewed enthusiasm is due in large part to phage therapy holding promise for providing safe and effective cures for bacterial infections that traditional antibiotics acting alone have been unable to clear. This Essay introduces basic phage biology, provides an outline of the long history of phage therapy, highlights some advantages of using phages as antibacterial agents, and provides an overview of recent phage therapy clinical successes. Although phage therapy has clear clinical potential, it faces biological, regulatory, and economic challenges to its further implementation and more mainstream acceptance.
噬菌体疗法是一种利用天然存在的病毒(称为噬菌体或噬菌体)作为抗菌剂来控制细菌感染的医学形式。噬菌体疗法早在 100 多年前就已开创先河,但目前人们对其兴趣正在重新高涨,越来越多的临床病例研究正在发表。这种新的热情在很大程度上归因于噬菌体疗法有望为治疗传统抗生素单独作用无法清除的细菌感染提供安全有效的方法。本文介绍了噬菌体的基本生物学特性,概述了噬菌体疗法的悠久历史,强调了将噬菌体用作抗菌剂的一些优势,并概述了最近噬菌体疗法的临床成功案例。尽管噬菌体疗法具有明显的临床潜力,但它在进一步实施和更广泛接受方面面临着生物学、监管和经济方面的挑战。